Ingestion of Beta-alanine Effects in Well-trained Tennis Players

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-11-04

Study Completion Date

2021-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Beta-alanine is considered as ergogenic aids with good to strong evidence for improving sports performance in specific sports context scenarios. However, most of the studies has been realized in endurance, with limited evidence in intermittent sports, especially in racket sports. Thus, the aim of this study was to explore the effects of 4-weeks ingestion of beta-alanine on neuromuscular performance in well-trained tennis players.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acute Supplementation With Beta-Alanine Improves Performance in Aerobic-anaerobic Transition Zones in Endurance Athletes

NCT05096793

Beta-alanine

COMPLETED NA

24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

NCT03655041

Sports Nutritional Physiological Phenomena

COMPLETED NA

The Effects of 4 Week β-alanine Supplementation on Knee Extensor Contractile and Force Properties in the Over 60s

NCT03111979

Muscle Function

SUSPENDED PHASE4

Supplementation in Tennis

NCT03232229

Supplements Tennis Nutrition

UNKNOWN

Beta-alanine Supplementation and High-intensity Interval Training

NCT03708185

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fourteen tennis players (23.3 ±3.7 years) between 50-250 national tennis ranking participated in this study. Participants were randomly divided into two groups that realized a neuromuscular battery after beta-alanine (4.8 gr/daily during 4-weeks) or placebo (i.e., fructose) (4.8 grams/daily during 4-weeks). Before and after the supplementation period tennis performed a neuromuscular test battery in a tennis court consisted in different test such as; serve velocity, countermovement jump, isometric handgrip strength, 10-m sprint, modified 5-0-5 agility test and repeated sprint ability. After 48 h of the realization of neuromuscular test battery, tennis players performed VO2max consumption test (i.e., treadmill).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Beta-alanine Placebo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Beta-alanine supplementation

Beta-alanine (4.8 grams) pills (Crown Nutrition, Haro, Spain) in four doses each day during a 4-week supplementation period.

Group Type ACTIVE_COMPARATOR

Beta-alanine supplementation

Intervention Type DIETARY_SUPPLEMENT

In a randomized order, two groups (n=7) was randomly assigned to beta-alanine and placebo during a 4-weeks period

Placebo supplementation

Placebo (4.8 grams) pills (Crown Nutrition, Haro, Spain) contain fructose (300mg) and excipients (1200 mg) such as cellulose, calcium phosphate, silicon dioxide and magnesium stearate in four doses each day during a 4-week supplementation period.

Group Type PLACEBO_COMPARATOR

Beta-alanine supplementation

Intervention Type DIETARY_SUPPLEMENT

In a randomized order, two groups (n=7) was randomly assigned to beta-alanine and placebo during a 4-weeks period

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Beta-alanine supplementation

In a randomized order, two groups (n=7) was randomly assigned to beta-alanine and placebo during a 4-weeks period

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Placebo supplementation

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Well-trained tennis players, between 18-35 years old (50-200 between tennis ranking)

Exclusion Criteria

* Suffering from any chronic pathology or an injury in the month prior to the investigation.
* Intolerance to beta-alanine ingestion
* Amateur tennis players.

Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes